IL212624A - Use of oxymethyl cellulose to control the emission and crystallization time of preparations containing one or more bioresor ceramics - Google Patents
Use of oxymethyl cellulose to control the emission and crystallization time of preparations containing one or more bioresor ceramicsInfo
- Publication number
- IL212624A IL212624A IL212624A IL21262411A IL212624A IL 212624 A IL212624 A IL 212624A IL 212624 A IL212624 A IL 212624A IL 21262411 A IL21262411 A IL 21262411A IL 212624 A IL212624 A IL 212624A
- Authority
- IL
- Israel
- Prior art keywords
- ejectability
- carboxymethylcellulose
- compositions
- control
- solidification time
- Prior art date
Links
- 229920002134 Carboxymethyl cellulose Polymers 0.000 title 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 title 1
- 239000001768 carboxy methyl cellulose Substances 0.000 title 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 title 1
- 239000000919 ceramic Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000008023 solidification Effects 0.000 title 1
- 238000007711 solidification Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/10—Ceramics or glasses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Composite Materials (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Ceramic Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polymers & Plastics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200801674 | 2008-11-27 | ||
| PCT/EP2009/008496 WO2010060644A1 (en) | 2008-11-27 | 2009-11-27 | Use of carboxymethylcellulose to control ejectability and solidification of time of compositions one or more bioresorbable ceramics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL212624A0 IL212624A0 (en) | 2011-07-31 |
| IL212624A true IL212624A (en) | 2017-09-28 |
Family
ID=40823443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL212624A IL212624A (en) | 2008-11-27 | 2011-05-02 | Use of oxymethyl cellulose to control the emission and crystallization time of preparations containing one or more bioresor ceramics |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9198884B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2376135B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5702294B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101632430B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102227228A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009319348B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2744141C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2376135T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2545962T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL212624A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2011005243A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2536415C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010060644A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201103805B (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105727370B (zh) * | 2016-02-18 | 2018-11-06 | 江苏西宏生物医药有限公司 | 一种注射植入剂 |
| US11752099B2 (en) | 2017-03-27 | 2023-09-12 | W. L. Gore & Associates, Inc. | Injectable and biodegradable polymer formulations for controlled release of bioactive agents |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB999487A (en) * | 1963-05-03 | 1965-07-28 | Ici Ltd | Set-retarded calcium sulphate hemihydrate |
| US3891453A (en) * | 1973-07-26 | 1975-06-24 | United States Gypsum Co | Asbestos-free joint compounds |
| GB1506897A (en) * | 1975-11-05 | 1978-04-12 | Ici Ltd | Method of securing fixing elements in rock |
| JPS5626756A (en) * | 1979-08-10 | 1981-03-14 | Sato Hironobu | Manufacture of alpha gypsum |
| HU197207B (en) * | 1985-12-04 | 1989-03-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical comprising 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydro-isoquinolinium-theophylline-7-acetate or its monohydrate as active ingredient |
| CA2268156C (en) | 1996-10-16 | 2007-05-29 | Etex Corporation | Bioceramic compositions |
| JP2000264710A (ja) * | 1999-03-23 | 2000-09-26 | Mitsui Chemicals Inc | 型材用流し込み組成物 |
| CA2378486A1 (en) | 1999-08-05 | 2001-02-15 | Takashi Kurasawa | Osteogenesis promoter sustained-release paste |
| US7371409B2 (en) * | 2001-09-06 | 2008-05-13 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| US7291179B2 (en) * | 2002-06-24 | 2007-11-06 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| US6652887B1 (en) * | 2002-06-24 | 2003-11-25 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| AU2002335562B2 (en) * | 2002-09-30 | 2007-07-05 | Regen Biotech, Inc. | Bone-filling composition for stimulating bone-forming and bone-consolidation comprising calcium sulfate and viscous biopolymers |
| WO2004108625A1 (en) * | 2003-06-05 | 2004-12-16 | Borden Chemical, Inc. | Gypsum products and method for their manufacture |
| PL1680089T3 (pl) * | 2003-10-22 | 2014-03-31 | Lidds Ab | Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków |
| US7671012B2 (en) * | 2004-02-10 | 2010-03-02 | Biosurface Engineering Technologies, Inc. | Formulations and methods for delivery of growth factor analogs |
| KR20140014294A (ko) * | 2005-03-31 | 2014-02-05 | 리드스 에이비 | 유효 물질의 국소 전달을 기본으로 하는 전립선 질병의 치료 방법 |
| AU2007224651B8 (en) * | 2006-03-14 | 2011-10-27 | Lidds Ab | Bioresorbable controlled-release composition |
| DE102008022086A1 (de) * | 2008-05-05 | 2009-11-12 | Schulz, Hans H. | Zweikomponenten-Alginat |
-
2009
- 2009-11-27 MX MX2011005243A patent/MX2011005243A/es active IP Right Grant
- 2009-11-27 RU RU2011126176/15A patent/RU2536415C2/ru active
- 2009-11-27 AU AU2009319348A patent/AU2009319348B2/en not_active Ceased
- 2009-11-27 WO PCT/EP2009/008496 patent/WO2010060644A1/en not_active Ceased
- 2009-11-27 DK DK09764455.3T patent/DK2376135T3/en active
- 2009-11-27 US US13/127,331 patent/US9198884B2/en active Active
- 2009-11-27 EP EP09764455.3A patent/EP2376135B1/en active Active
- 2009-11-27 JP JP2011537896A patent/JP5702294B2/ja active Active
- 2009-11-27 ES ES09764455.3T patent/ES2545962T3/es active Active
- 2009-11-27 CN CN2009801477087A patent/CN102227228A/zh active Pending
- 2009-11-27 CA CA2744141A patent/CA2744141C/en active Active
- 2009-11-27 KR KR1020117014428A patent/KR101632430B1/ko not_active Expired - Fee Related
-
2011
- 2011-05-02 IL IL212624A patent/IL212624A/en active IP Right Grant
- 2011-05-24 ZA ZA2011/03805A patent/ZA201103805B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2536415C2 (ru) | 2014-12-20 |
| RU2011126176A (ru) | 2013-01-10 |
| ZA201103805B (en) | 2018-11-28 |
| EP2376135A1 (en) | 2011-10-19 |
| KR20110102357A (ko) | 2011-09-16 |
| DK2376135T3 (en) | 2015-08-31 |
| CA2744141C (en) | 2016-12-13 |
| MX2011005243A (es) | 2011-08-08 |
| IL212624A0 (en) | 2011-07-31 |
| CN102227228A (zh) | 2011-10-26 |
| HK1168562A1 (en) | 2013-01-04 |
| AU2009319348A1 (en) | 2010-06-03 |
| AU2009319348B2 (en) | 2014-07-31 |
| WO2010060644A1 (en) | 2010-06-03 |
| JP2012509919A (ja) | 2012-04-26 |
| CA2744141A1 (en) | 2010-06-03 |
| EP2376135B1 (en) | 2015-05-27 |
| US9198884B2 (en) | 2015-12-01 |
| KR101632430B1 (ko) | 2016-06-21 |
| JP5702294B2 (ja) | 2015-04-15 |
| US20110223214A1 (en) | 2011-09-15 |
| ES2545962T3 (es) | 2015-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT2364360T (lt) | Priešprasmės kompozicijos ir jų gavimo bei panaudojimo būdai | |
| ZA201107789B (en) | Antimicrobial composition and related method of use | |
| GB2469245B (en) | Antimicrobial compositions and methods of use thereof | |
| IL217280A0 (en) | Compositions comprising combinations of phyto-cannabinoids and uses thereof | |
| IL218057A0 (en) | Compositions comprising carboxamide compounds and uses thereof | |
| ZA201008713B (en) | Antimicrobial compositions and methods of use | |
| ZA201008232B (en) | Lipid-containing compositions and methods of use thereof | |
| IL216159A0 (en) | Sublingual dexmedetomidine compositions and method of use thereof | |
| EP2346324A4 (en) | ANTIMICROBIAL COMPOSITION AND METHODS OF MAKING AND USING | |
| EP2326171A4 (en) | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE | |
| EP2231665A4 (en) | NEW COMPOSITIONS AND METHODS OF USE | |
| PL2252669T3 (pl) | Kompozycja typu azeotropu 1,1,1-trifluoro-3-chloropropenu (HCFO-1233zd) i octanu metylu | |
| IL208403A0 (en) | Compositions and use of epas1 inhibitors | |
| EP2234628A4 (en) | COMPOSITIONS AND METHODS FOR PROMOTING WOUND HEALING | |
| IL212219A0 (en) | Compositions comprising pyrone analogs and uses thereof | |
| EP2183335A4 (en) | MICROPOSITION COMPOSITION AND USE METHOD THEREFOR | |
| PL2179657T3 (pl) | Kompozycje z efuzją gazu i sposób ich wytwarzania | |
| PT2291474T (pt) | Composição decorativa e método para a sua utilização | |
| ZA201102207B (en) | Cinnamandehyde-allicin compositions and their method of use | |
| GB0812890D0 (en) | Compositions and methods of making compositions | |
| EP2421923A4 (en) | INK COMPOSITIONS AND USE | |
| IL207827A0 (en) | Apoaequorin-containing compositions and methods of using same | |
| ZA201103805B (en) | Use of carboxymethylcellulose to control ejectability and solidification time of compositions comprising one or more bioresorbable ceramics | |
| EP2381950A4 (en) | COMPOSITIONS AND METHOD FOR THEIR USE | |
| ZA201007397B (en) | Delayed release compositions of duloxetine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |